| Sentara Health Plans Avalon | G2138: Evaluation of Dry Eyes | 2026-08-01 |
| Sentara Health Plans Avalon | G2143: Lyme Disease Testing | 2026-08-01 |
| Sentara Health Plans Avalon | G2148: Genetic Testing for Hereditary Hearing Loss | 2026-08-01 |
| Sentara Health Plans Avalon | G2153: Pancreatic Enzyme Testing for Acute Pancreatitis | 2026-08-01 |
| Sentara Health Plans Avalon | G2154: Folate Testing | 2026-08-01 |
| UHC Surest Medical and Drug | Encelto® (Revakinagene Taroretcel-Lwey) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-08-01 |
| UHC Surest Medical and Drug | Entyvio® (Vedolizumab) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-08-01 |
| UHC Surest Medical and Drug | Intracanalicular and Intravitreal Corticosteroid Implants – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-08-01 |
| UHC Surest Medical and Drug | Kebilidi® (Eladocagene Exuparvovec-Tneq) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-08-01 |
| UHC Surest Medical and Drug | Maximum Dosage and Frequency – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-08-01 |